Scientists at Feinberg’s Cognitive Neurology and Alzheimer’s Disease Center have received a five-year, $2.28 million NIH grant to continue studying SuperAgers, people over 80 with remarkable, age-defying memory power.
Doctors are more likely to try a new therapy when they are persuaded to do so by an influential colleague, according to a Northwestern Medicine study on adopting innovations in clinical practice.
A nano-sized discovery by Northwestern Medicine scientists helps explain how bipolar disorder affects the brain and could one day lead to new drug therapies to treat the mental illness.
Feinberg faculty received an NIH grant to build a microphysiologic model of the female reproductive system to predict drug safety and effectiveness in humans.
A new Northwestern Medicine study identified the pathway that mediates the link between diabetes and cardiomyopathy.
Northwestern Medicine scientists have discovered that a specific type of white blood cell’s behavior may explain how rheumatoid arthritis develops.
Northwestern Medicine scientists identified the same protein deposits that are usually found in the brains of ALS patients in the retina, opening a new potential avenue for diagnosing and tracking the disease.
Northwestern Medicine scientists created a more objective, precise and quicker way to test the effectiveness of multiple sclerosis drugs that may promote the repair of myelin, a protective sheath on neurons.
Katherine Barsness, MD, ’11 MS, created life-sized, reusable models of a newborn’s ribcage with 3-D printing technology to provide uniquely authentic simulation-based education to training pediatric surgeons.
Northwestern Medicine investigators found that redesigning the instructions that accompany prescribed medications increases patient comprehension, helping to ensure that drugs with serious side effects are used safely.